Andrew Makrides's most recent trade in Apyx Medical Corp was a trade of 17,000 Stock Option (Option to Buy) done . Disclosure was reported to the exchange on Aug. 10, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Apyx Medical Corp | Andrew Makrides | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 17,000 | 17,000 | - | - | Stock Option (Option to Buy) | |
| Apyx Medical Corp | Andrew Makrides | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2022 | 17,000 | 17,000 | - | - | Stock Option (Option to Buy) | |
| Apyx Medical Corp | Andrew Makrides | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.54 per share. | 05 Jul 2022 | 30,000 | 637,972 (1%) | 0% | 2.5 | 76,200 | Common Stock |
| Apyx Medical Corp | Andrew Makrides | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jul 2022 | 30,000 | 0 | - | - | Stock Option (Option to Buy) | |
| Apyx Medical Corp | Andrew Makrides | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.14 per share. | 05 Jul 2022 | 13,583 | 624,389 (1%) | 0% | 6.1 | 83,400 | Common Stock |
| Apyx Medical Corp | Andrew Makrides | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2021 | 17,000 | 17,000 | - | - | Stock Option (Option to Buy) | |
| Apyx Medical Corp | Andrew Makrides | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2020 | 17,000 | 17,000 | - | - | Stock Option (Option to Buy) |